Stock Scorecard
Stock Summary for NeuroOne Medical Technologies Corp (NMTC) - $0.76 as of 12/20/2024 3:52:27 PM EST
Total Score
9 out of 30
Safety Score
9 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for NMTC
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NMTC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NMTC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NMTC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for NMTC (9 out of 100)
| Stock Price Rating (Max of 10) | 1 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 3 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for NMTC
Financial Details for NMTC
Company Overview |
|
|---|---|
| Ticker | NMTC |
| Company Name | NeuroOne Medical Technologies Corp |
| Country | USA |
| Description | NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota. |
| Sector Name | REAL ESTATE & CONSTRUCTION |
| Industry Name | PATENT OWNERS & LESSORS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 2/11/2025 |
Stock Price History |
|
| Last Day Price | 0.76 |
| Price 4 Years Ago | 4.71 |
| Last Day Price Updated | 12/20/2024 3:52:27 PM EST |
| Last Day Volume | 99,997 |
| Average Daily Volume | 236,116 |
| 52-Week High | 1.72 |
| 52-Week Low | 0.55 |
| Last Price to 52 Week Low | 38.18% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.03 |
| Sector PE | 64.54 |
| 5-Year Average PE | -2.74 |
| Free Cash Flow Ratio | 15.20 |
| Industry Free Cash Flow Ratio | 15.38 |
| Sector Free Cash Flow Ratio | 107.01 |
| Current Ratio Most Recent Quarter | 2.09 |
| Total Cash Per Share | 0.05 |
| Book Value Per Share Most Recent Quarter | 0.11 |
| Price to Book Ratio | 28.45 |
| Industry Price to Book Ratio | 3.31 |
| Sector Price to Book Ratio | 12.37 |
| Price to Sales Ratio Twelve Trailing Months | 5.96 |
| Industry Price to Sales Ratio Twelve Trailing Months | 6.93 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.11 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 30,841,800 |
| Market Capitalization | 23,439,768 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -3.87% |
| Reported EPS 12 Trailing Months | -0.46 |
| Reported EPS Past Year | -0.46 |
| Reported EPS Prior Year | -0.65 |
| Net Income Twelve Trailing Months | -12,318,110 |
| Net Income Past Year | -12,318,110 |
| Net Income Prior Year | -11,859,491 |
| Quarterly Revenue Growth YOY | 31.10% |
| 5-Year Revenue Growth | 613.83% |
| Operating Margin Twelve Trailing Months | -3.38 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,460,042 |
| Total Cash Past Year | 1,460,042 |
| Total Cash Prior Year | 2,680,985 |
| Net Cash Position Most Recent Quarter | 1,460,042 |
| Net Cash Position Past Year | 1,460,042 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 1,007,206 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 822,013 |
| Total Stockholder Equity Prior Year | 4,418,156 |
| Total Stockholder Equity Most Recent Quarter | 822,013 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -11,132,037 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.36 |
| Free Cash Flow Past Year | -11,132,037 |
| Free Cash Flow Prior Year | -13,270,991 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | -0.02 |
| 20-Day Bollinger Lower Band | 0.59 |
| 20-Day Bollinger Middle Band | 0.82 |
| 20-Day Bollinger Upper Band | 1.05 |
| Beta | 0.91 |
| RSI | 48.33 |
| 50-Day SMA | 1.00 |
| 150-Day SMA | 1.26 |
| 200-Day SMA | 2.20 |
System |
|
| Modified | 12/21/2024 7:34:54 AM EST |